Sildenafil can be a strong and selective inhibitor of cGMP-unique phosphodiesterase type five (PDE5), which is responsible for degradation of cGMP in the corpus cavernosum. The molecular composition of sildenafil is analogous to that of cGMP and acts like a competitive binding agent of PDE5 during the corpus cavernosum, leading to a lot more cGMP a